An independent panel of experts advising the Food and Drug Administration voted on Tuesday on to recommend to the agency that Moderna’s coronavirus vaccine be authorized for children and adolescents ages 6 to 17. The panel’s recommendation was a key step as federal regulators weigh authorizing the vaccine for those …
Read More »